Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphoma
Autolus Limited
Autolus Limited
Corvus Pharmaceuticals, Inc.
National Institutes of Health Clinical Center (CC)
SecuraBio
Mayo Clinic
Fudan University
Fondazione Italiana Linfomi - ETS
Case Comprehensive Cancer Center
City of Hope Medical Center
Mayo Clinic
SciTech Development, Inc.
Barbara Ann Karmanos Cancer Institute
City of Hope Medical Center
City of Hope Medical Center
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Bristol-Myers Squibb
Washington University School of Medicine
BeiGene
Stanford University
University of Nebraska
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Northwestern University
University of Nebraska
University of Nebraska
Eastern Cooperative Oncology Group
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Zhejiang University
Northwestern University
Roswell Park Cancer Institute
Universität des Saarlandes
Fred Hutchinson Cancer Center
Celgene
Barbara Ann Karmanos Cancer Institute
Mayo Clinic
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Canadian Cancer Trials Group
Barbara Ann Karmanos Cancer Institute
Mayo Clinic
Shandong Provincial Hospital
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Wisconsin, Madison
Mayo Clinic